SKI Market

A+| A| A-|

Indian Indices

Sensex

77,776.85 -374.60
( -0.48%)

Global Indices

Nasdaq

52,169.86 -404.11
(-0.77%)

Dow Jones

7,480.34 -74.43
(-0.99%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,574.52 2.28
(0.02%)

Forex

USD-INR

96.36 0.10
(0.10%)

EUR-INR

110.37 0.25
(0.23%)

GBP-INR

130.11 0.62
(0.47%)

JPY-INR

0.59 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ipca Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524494

INE571A01038

314.5139046

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IPCALAB

42.54

48324.31

EPS(TTM)

Face Value()

Div & Yield %

44.78

0.32

Back

Dhruv Consultancy Services reports consolidated net loss of Rs 31.01 crore in the December 2025 quarter

Feb 13,2026

Net loss of Dhruv Consultancy Services reported to Rs 31.01 crore in the quarter ended December 2025 as against net profit of Rs 2.15 crore during the previous quarter ended December 2024. Sales reported to Rs -5.69 crore in the quarter ended December 2025 as against Rs 21.99 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	-5.69	21.99	PL
OPM %	517.93	17.78	-
PBDT	-29.69	3.80	PL
PBT	-30.87	2.64	PL
NP	-31.01	2.15	PL

77,776.85 -374.60 ( -0.48%)

52,169.86 -404.11 (-0.77%)

7,480.34 -74.43 (-0.99%)

63,887.74 -2,947.80 (-4.41%)

10,574.52 2.28 (0.02%)

96.36 0.10 (0.10%)

110.37 0.25 (0.23%)

130.11 0.62 (0.47%)

0.59 0.00 (0.06%)